國立虎尾科技大學 |

Genome editing = the next step in gene therapy /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Genome editing/ edited by Toni Cathomen, Matthew Hirsch, Matthew Porteus.
Reminder of title:	the next step in gene therapy /
other author:	Cathomen, Toni.
Published:	New York, NY :Springer New York : : 2016.,
Description:	xvi, 263 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
Subject:	Genetic engineering. -
Online resource:	http://dx.doi.org/10.1007/978-1-4939-3509-3
ISBN:	9781493935093

Genome editing = the next step in gene therapy /
Genome editingthe next step in gene therapy /[electronic resource] :edited by Toni Cathomen, Matthew Hirsch, Matthew Porteus. - New York, NY :Springer New York :2016. - xvi, 263 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.8950065-2598 ;. - Advances in experimental medicine and biology ;780..

1. Gene Editing: Double-Strand Break Induced Gene Targeting and Mutagenesis 20 Years Later -- 2. The Development and Use of Zinc-Finger Nucleases -- 3.The Use and Development of TAL Effector Nucleases -- 4. Genome Editing for Neuromuscular Diseases -- 5. Phage Integrases for Genome Editing -- 6. Precise Genome Modification Using Triplex Forming Oligonucleotides and Peptide Nucleic Acids -- 7. Genome Editing by Aptamer-Guided Gene Targeting -- 8. Stimulation of AAV Gene Editing via DSB Repair -- 9. Engineered Nucleases and Trinucleotide Repeat Diseases -- 10. Using Engineered Nucleases to Create HIV-Resistant Cells -- 11. Strategies to Determine Off-Target Effects of Engineered Nucleases.

This comprehensive volume explores human genetic engineering its pre-clinical and clinical applications, current developments, and as treatment for hereditary diseases. It presents and evaluates the most recent advances in the understanding of mammalian host DNA repair mechanisms, such as double-strand break induced gene targeting and mutagenesis, the development of zinc-finger nucleases, genome editing for neuromuscular diseases, phase integrases, triplex forming oligonucleotides and peptide nucleic acids, aptamer-guided gene targeting, AAV gene editing via DSB repair, engineered nucleases and trinucleotide repeat diseases, and creation of HIV-resistant cells. The expertly authored chapters contextualize current developments within the history of genome editing while also discussing the current and potential safety concerns of this rapidly growing field. Genome Editing: The Next Step in Gene Therapy, the latest volume in the American Society of Gene and Cell Therapy series, deftly illuminates the potential of genetic engineering technology to eradicate today's deadliest and most prolific diseases. It is ideal reading for clinicians and researchers in genetics and immunology.

ISBN: 9781493935093

Standard No.: 10.1007/978-1-4939-3509-3doiSubjects--Topical Terms:

592227
Genetic engineering.

LC Class. No.: QH442

Dewey Class. No.: 660.65

Genome editing = the next step in gene therapy /
LDR:02946nam a2200325 a 4500 001 862812
003 DE-He213
005 20160908152816.0
006 m d
007 cr nn 008maaau
008 170720s2016 nyu s 0 eng d
020 $a 9781493935093 $q (electronic bk.)
020 $a 9781493935079 $q (paper)
024 7 $a 10.1007/978-1-4939-3509-3 $2 doi
035 $a 978-1-4939-3509-3
040 $a GP $c GP
041 0 $a eng
050 4 $a QH442
072 7 $a MFN $2 bicssc
072 7 $a MED107000 $2 bisacsh
082 0 4 $a 660.65 $2 23
090 $a QH442 $b .G335 2016
245 0 0 $a Genome editing $h [electronic resource] : $b the next step in gene therapy / $c edited by Toni Cathomen, Matthew Hirsch, Matthew Porteus.
260 $a New York, NY : $b Springer New York : $b Imprint: Springer, $c 2016.
300 $a xvi, 263 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.895
505 0 $a 1. Gene Editing: Double-Strand Break Induced Gene Targeting and Mutagenesis 20 Years Later -- 2. The Development and Use of Zinc-Finger Nucleases -- 3.The Use and Development of TAL Effector Nucleases -- 4. Genome Editing for Neuromuscular Diseases -- 5. Phage Integrases for Genome Editing -- 6. Precise Genome Modification Using Triplex Forming Oligonucleotides and Peptide Nucleic Acids -- 7. Genome Editing by Aptamer-Guided Gene Targeting -- 8. Stimulation of AAV Gene Editing via DSB Repair -- 9. Engineered Nucleases and Trinucleotide Repeat Diseases -- 10. Using Engineered Nucleases to Create HIV-Resistant Cells -- 11. Strategies to Determine Off-Target Effects of Engineered Nucleases.
520 $a This comprehensive volume explores human genetic engineering its pre-clinical and clinical applications, current developments, and as treatment for hereditary diseases. It presents and evaluates the most recent advances in the understanding of mammalian host DNA repair mechanisms, such as double-strand break induced gene targeting and mutagenesis, the development of zinc-finger nucleases, genome editing for neuromuscular diseases, phase integrases, triplex forming oligonucleotides and peptide nucleic acids, aptamer-guided gene targeting, AAV gene editing via DSB repair, engineered nucleases and trinucleotide repeat diseases, and creation of HIV-resistant cells. The expertly authored chapters contextualize current developments within the history of genome editing while also discussing the current and potential safety concerns of this rapidly growing field. Genome Editing: The Next Step in Gene Therapy, the latest volume in the American Society of Gene and Cell Therapy series, deftly illuminates the potential of genetic engineering technology to eradicate today's deadliest and most prolific diseases. It is ideal reading for clinicians and researchers in genetics and immunology.
650 0 $a Genetic engineering. $3 592227
650 0 $a Gene therapy. $3 582271
650 1 4 $a Biomedicine. $3 593880
650 2 4 $a Human Genetics. $3 593893
700 1 $a Cathomen, Toni. $3 1106437
700 1 $a Hirsch, Matthew. $3 1106438
700 1 $a Porteus, Matthew. $3 1106439
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 780. $3 881230
856 4 0 $u http://dx.doi.org/10.1007/978-1-4939-3509-3
950 $a Biomedical and Life Sciences (Springer-11642)